Article
BuCy RAFs drive cells into MEK addiction.
Cancer cell - 1 Jan 2006
Rapp Ulf R, Götz Rudolf, Albert Stefan
Abstract excerpt
RAF research is booming since the discovery of mutant B-RAF in approximately 8% of human cancer. One reason for the excitement is the availability of RAF-targeted therapies. RAF inhibitors have been developed because RAF functions at a convergence point of signal transduction. Two recent papers by the groups of Rosen and Marais dramatically advance our understanding of RAF oncogenes in human tumors. The results...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
